Replication protein A prevents accumulation of single-stranded telomeric DNA in cells that use alternative lengthening of telomeresActivated platelets provide a functional microenvironment for the antiangiogenic fragment of histidine-rich glycoproteinIn vivo models of primary brain tumors: pitfalls and perspectives.Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanomaDeletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor functionCD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cellsStimulation of extracellular matrix components in the normal brain by invading glioma cellsNG2 expression regulates vascular morphology and function in human brain tumoursCritical appraisal of the side population assay in stem cell and cancer stem cell researchBromelain reversibly inhibits invasive properties of glioma cellsCell encapsulation technology as a therapeutic strategy for CNS malignanciesInference of Low and High-Grade Glioma Gene Regulatory Networks Delineates the Role of Rnd3 in Establishing Multiple Hallmarks of CancerComprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastomaCellular host responses to gliomasGene set based integrated data analysis reveals phenotypic differences in a brain cancer model.The brain slice chamber, a novel variation of the Boyden Chamber Assay, allows time-dependent quantification of glioma invasion into mammalian brain in vitro.Dynamic determination of human glioma invasion in vitro.Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumorsTwo distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics.Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype.A reproducible brain tumour model established from human glioblastoma biopsiesαB-crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells.The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling.Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein.In vitro treatment of melanoma brain metastasis by simultaneously targeting the MAPK and PI3K signaling pathways.Retroviral transfection of the lacZ gene from Liz-9 packaging cells to glioma spheroids.Local endostatin treatment of gliomas administered by microencapsulated producer cells.Interstitial fluid: the overlooked component of the tumor microenvironment?HAMLET kills tumor cells by an apoptosis-like mechanism--cellular, molecular, and therapeutic aspects.Mesenchymal stem cell signaling in cancer progression.Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers?A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.Localised delivery of therapeutic agents to CNS malignancies: old and new approaches.Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.Tumor versus stromal cells in culture--survival of the fittest?Angiogenesis-independent tumor growth mediated by stem-like cancer cells.Mechanisms of tumor cell invasion and angiogenesis in the central nervous system.Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDH1R132 mutation effects in human glioblastoma.
P50
Q24298583-E04D542A-A83F-499B-945B-A83B22F66513Q24316062-36CFA385-F2BB-4800-8119-6D80D2CE9824Q26862847-1BC8C250-035E-47A8-AD52-F0BE89A4C777Q27326700-BA369C64-897E-4F0D-A286-5FF07B649479Q28119050-C165B14B-7CC2-4F90-9A6A-AD1E51A4C1FFQ28254370-33D6806E-F7B2-41AD-8DB7-F18C836C1CD0Q28264917-8DE78AC0-0AA7-4CE6-856D-A94BE1B45AB2Q28279236-B03B4E3C-CBEE-4A60-B95C-B499A945ED5FQ28304721-9B880023-3F42-4360-B8F2-2AD719817FA3Q28344466-36081331-739D-428E-925C-8D9D5A64A1E4Q28344622-9AF0CD7F-0F75-4A6D-8A4A-D69CB79DBF11Q28546030-5570B8A2-286E-4248-B565-7D9146C91D2CQ28546923-CFAB7061-5576-43D6-9D28-89B4A33ADCBCQ28730429-62142490-8E54-4922-BDEA-4513D27B6C65Q30656585-093FB8F9-3BF6-45F7-BC6D-49C8AEBBC218Q30854400-4058C30C-BAE4-41DA-9280-A4A37F5BC5C2Q32029036-6A5E8043-42A6-445B-BCDE-245EAAA9AF0CQ33270954-4784D56E-160D-4F72-85AF-1498968C2905Q33350283-C25C26AA-A1A5-47B7-B7F3-2799CCDEEA43Q33484184-98D7B23E-FA56-4FF0-A306-4C205165F10CQ33493026-54DEC0D1-26CC-4A03-B815-673204A8DFBDQ33521101-08D2D35E-5163-4CFC-8204-B7B1632E9571Q33683216-A9899578-5403-42A3-979A-9F5A1EFC9BFCQ33704281-18FD2CED-F3D2-4C53-A55B-824A96B44D9CQ33751911-60785D7B-0A90-4E52-8069-CF07C2666366Q33755862-FF03B82E-E92D-4B1D-99FB-81FFBB19928EQ33778711-7F263005-A89F-46D9-8D17-91EE9380211AQ33929689-83532A87-FEF5-4DC8-AEB8-4C3395BD93CAQ34060641-E3F7B5BC-07AC-4046-A497-A01B6BC8A2B7Q34186956-34382F94-047D-4953-A005-386465A0E8D0Q34267450-BEDFD8B1-785A-4A2E-A44D-F5982558F5F9Q34416029-369B6E46-01E0-493A-B17E-11FBD19C1741Q34635517-812C0E24-A3BF-4362-9C6E-E9381EF9E33AQ34775090-82D4CF0A-7476-475E-B29D-233DD04C2AE2Q35006426-E879629C-5D9C-484A-9E4F-73D92D22E9DEQ35069499-2A359FCB-37BE-4E6C-8112-186B34F3D824Q35103863-1E87D675-2D27-4FE7-BF1B-88D258585479Q35109327-4844875A-D8D2-4A0F-8C16-8017D404DDFFQ35257150-8C1BB9F2-E43C-494B-8411-460B91B889B0Q35441165-BDF67AA2-31BC-44FA-88A2-A7DF271C3CA3
P50
description
Noors professor
@nl
Norsk kreftforsker og professor
@nb
name
Rolf Bjerkvig
@ast
Rolf Bjerkvig
@ca
Rolf Bjerkvig
@da
Rolf Bjerkvig
@en
Rolf Bjerkvig
@es
Rolf Bjerkvig
@fr
Rolf Bjerkvig
@ga
Rolf Bjerkvig
@nb
Rolf Bjerkvig
@nl
Rolf Bjerkvig
@sl
type
label
Rolf Bjerkvig
@ast
Rolf Bjerkvig
@ca
Rolf Bjerkvig
@da
Rolf Bjerkvig
@en
Rolf Bjerkvig
@es
Rolf Bjerkvig
@fr
Rolf Bjerkvig
@ga
Rolf Bjerkvig
@nb
Rolf Bjerkvig
@nl
Rolf Bjerkvig
@sl
prefLabel
Rolf Bjerkvig
@ast
Rolf Bjerkvig
@ca
Rolf Bjerkvig
@da
Rolf Bjerkvig
@en
Rolf Bjerkvig
@es
Rolf Bjerkvig
@fr
Rolf Bjerkvig
@ga
Rolf Bjerkvig
@nb
Rolf Bjerkvig
@nl
Rolf Bjerkvig
@sl
P214
P21
P214
P27
P31
P569
1953-01-01T00:00:00Z
P735
P7859
lccn-n88211520